
Kevin Kalinsky, MD, MS, FASCO
@kalinskykevin
Division Director of Medical Oncology at Winship/Director Glenn Family Breast Center/Opinions=my own
ID: 1087816554400698379
https://winshipcancer.emory.edu/bios/faculty/kalinsky-kevin.html 22-01-2019 20:57:32
190 Tweet
2,2K Followers
150 Following

Kevin Kalinsky, MD, MS, FASCO Sara Tolaney Melinda Telli, M.D. Komal Jhaveri 3/21 T-DXd, SG, and Dato-DXd have been tested in phase III trials. All 3 ADCs inhibit topoisomerase I, but there are slight differences in their cytotoxic payloads. #DESTINY-Breast04 #TROPiCS-02 #TROPIONBreast01 Kevin Kalinsky, MD, MS, FASCO #medtwitter #tweetorial #Xtorial


Kevin Kalinsky, MD, MS, FASCO Sara Tolaney Melinda Telli, M.D. Komal Jhaveri Hope Rugo Aditya Bardia, MD Paolo Tarantino 6/21 ⚠Unique toxicities associated with T-DXd include ILD. This is an important AE associated with T-DXd that everyone needs to be aware of so that appropriate and careful monitoring and management are performed.


Kevin Kalinsky, MD, MS, FASCO Sara Tolaney Melinda Telli, M.D. Komal Jhaveri Hope Rugo Aditya Bardia, MD Paolo Tarantino 19/21 💭Several HER2-directed ADCs are currently in clinical development ⏲. #MedX #Xtorial #Tweetorial #MedTwitter


Kevin Kalinsky, MD, MS, FASCO Sara Tolaney Melinda Telli, M.D. Komal Jhaveri Hope Rugo Aditya Bardia, MD Paolo Tarantino 21/21 🎆Thank you for scrolling down this far, following our conversation, and reinforcing your knowledge of ADC for #breastcancer! Go online for more CCO education! clinicaloptions.com/BreastTROP2HER… Thank you to Kevin Kalinsky, MD, MS, FASCO for this #breastcancer #xtorial 🧵 #MedX



Very much looking forward to this! Research To Practice Heather McArthur, MD, MPH Winship Cancer Institute of Emory University #bcsm

Looking forward to this discussion! #bcsm Winship Cancer Institute of Emory University


A new commentary published just in time for Day 1 of #SABCS24 covers past-year top advances in early-stage and metastatic #BreastCancer. Hear from author Kevin Kalinsky, MD, MS, FASCO below & access the article: acsjournals.onlinelibrary.wiley.com/doi/full/10.10… OncoAlert Winship Cancer Institute of Emory University Ruth O'Regan Suresh S. Ramalingam, MD, FASCO

New Journal of Clinical Oncology📰| #Abemaciclib Plus #Fulvestrant in Advanced #BreastCancer Following Progression on CDK4/6 Inhibition: Results from the Phase III postMONARCH Trial 🔓pubmed.ncbi.nlm.nih.gov/39693591/ ✍️Kevin Kalinsky, MD, MS, FASCO Giampaolo Bianchini Erika Hamilton, MD Stephanie Graff, MD, FACP, FASCO Rinath Jeselsohn Dr Sarah Sammons Montserrat Muñoz Mateu



In Journal of Clinical Oncology: A new statistical tool combining clinical and pathologic factors w a patient's 21-gene Recurrence Score® gives more accurate estimates on #breastcancer prognosis & potential chemo benefit than any of the factors alone. #bcsm Yale Cancer Center swog.org/news-events/ne…


Analysis of RxPONDER trial data by Yara Abdou, et al, in @JNCI_now highlights persistent racial disparities in #breastcancer outcomes. doi.org/10.1093/jnci/d… #bcsm #HealthDisparities UNC Lineberger Kevin Kalinsky, MD, MS, FASCO IBC Research Fdn Roberta A Albany Julie Gralow Debu Tripathy, MD DrJoeUnger

Tari King appointed chief surgical officer for cancer service line, co-director of Glenn Family Breast Center at Winship Cancer Institute of Emory University, chief of Division of Breast Surgery at Emory cancerletter.com/in-brief/20250…


Looking forward to advocating for our patients w cancer along w Wendy Baer MD @asco Winship Cancer Institute of Emory University Emory University #ASCOAdvocacySummit



Meaningful day on the Hill advocating for cancer research, improving access to care, and ending drug shortages w Wendy Baer MD ASCO Winship Cancer Institute of Emory University Emory University #ASCOAdvocacySummit


I am much looking forward to this! See you in Chicago.Winship Cancer Institute of Emory University
